抗磷酸胆碱IgM作为一种抗炎介质可预测外周静脉移植物失败:一项前瞻性观察性研究
本研究为前瞻性观察性队列研究,纳入四所大学附属医院接受腹股沟下自体静脉旁路的142例连续患者,术前抗-PC IgM最低四分位组移植物失败风险为两倍(HR 2.11,95%CI 1.09-4.07,p=0.03)。
要点
- 术前抗-PC IgM最低四分位者移植物失败风险为两倍(HR 2.11,95%CI 1.09-4.07,p=0.03)。
- 术前IL-6或CRP水平未预测移植物失败。
- 抗-PC IgM可能有助于识别高风险患者。
核心结论
- 低水平抗-PC IgM与静脉旁路移植物失败相关,该生物介质可能有助于识别高风险患者。
研究设计与样本
- 前瞻性观察性队列研究,纳入四所大学附属医院接受腹股沟下自体静脉旁路治疗外周动脉闭塞性疾病的连续患者。
- 共纳入142例连续患者,平均年龄66岁(范围46-91岁),91%为白种人及男性,72.5%为严重肢体缺血(Fontaine III或IV期)。
- 术前和术后测量血浆细胞因子和抗-PC IgM水平,随访平均1.8年(范围1个月至7.4年)。
主要发现
- 随访期间50例(35.2%)移植物失去初级通畅性。
- 术前抗-PC IgM中位数为49单位/mL(IQR 32.3-107.7,均值89.8±101 SD)。
- 术前抗-PC IgM最低四分位组移植物失败风险为两倍(多变量Cox比例风险,p=0.03,HR 2.11,95%CI 1.09-4.07),校正其他显著因素(导管直径、远端吻合、吸烟和腿缺血严重程度)后仍显著。
- 术前白细胞介素6或C反应蛋白水平未预测移植物失败。
临床怎么用
- 低水平抗-PC IgM可能作为识别静脉旁路移植物失败高风险患者的标志物,并可能为血管炎症及其后果提供新的定向治疗方向。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: One third of infrainguinal vein bypasses may fail within the first 1.5 years. Pro- and anti-inflammatory mechanisms are thought to be involved in these graft stenoses and occlusions. In previous studies, low levels of anti-phosphorylcholine IgM (anti-PC IgM, an innate anti-inflammatory IgM) have been associated with increased cardiovascular events. In this study, the peri-operative dynamics of anti-PC IgM levels were established during leg bypass surgery, and associations assessed between anti-PC IgM levels and primary graft patency. DESIGN AND METHODS: This was a prospective, observational cohort study of infrainguinal autogenous vein bypass for peripheral arterial occlusive disease involving four university affiliated hospitals. Plasma cytokine and anti-PC IgM levels were measured pre- and post-operatively. The outcome of interest was loss of primary graft patency because of occlusion or intervention for graft stenosis. RESULTS: One hundred and forty-two consecutive patients were enrolled: mean age 66 (46-91); 91% white race and male; 72.5% critical limb ischaemia (Fontaine III or IV). Median pre-operative anti-PC IgM levels were 49 units/mL (IQR 32.3-107.7, mean 89.8 + 101 sd). During follow up of an average of 1.8 years (1 month-7.4 years), 50 (35.2%) grafts lost primary patency. Pre-operative levels of interleukin 6 or C-reactive protein did not predict graft failure. Patients with pre-operative anti-PC IgM values in the lowest quartile had a twofold increased risk of graft failure (multivariable Cox proportional hazard, p = .03, HR 2.11, 95% CI 1.09-4.07), even after accounting for the other significant factors of conduit diameter, distal anastomosis, smoking, and the severity of leg ischaemia. CONCLUSIONS: Low levels of anti-PC IgM are associated with vein bypass graft failure. This biological mediator may be a useful marker to identify patients at higher risk, and offers the potential for novel, directed therapies for vascular inflammation and its consequences.
引用
- Sobel M, Yagi M, Moreno K, et al. Anti-phosphorylcholine IgM, an Anti-inflammatory Mediator, Predicts Peripheral Vein Graft Failure: A Prospective Observational Study. Eur J Vasc Endovasc Surg. 2018. PMID: 30343000. doi:10.1016/j.ejvs.2018.09.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。